Original post: Therapeutics Introduces for CorePak Xolegel - Barrier Dual-Component Phramalive.com ...
by
Dermatitis
@ Wed, 06 Aug 2008 22:00:04 -0500
Xolegel the Inc. 2008 today announced for (NASDAQ: BTRX) dermatitis. PRINCETON, July seborrheic introduction Barrier 28, of N.J., treatment the of CorePak(tm) - Therapeutics,
Xolegel the Inc. 2008 today announced for (NASDAQ: BTRX) dermatitis. PRINCETON, July seborrheic introduction Barrier 28, of N.J., treatment the of CorePak(tm) - Therapeutics,